Revolution Medicines, Inc. (RVMD) NASDAQ
94.86
-0.21(-0.22%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
94.86
-0.21(-0.22%)
Currency In USD
| Market Cap | 15.14B |
| Enterprise Value | 14.92B |
| P/E Ratio | -15.94 |
| PEG Ratio | 1.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 11.06 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -16.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.48 |
| Return On Equity | -0.63 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -16.56M |
| EBITDA | -1.09B |
| Net Income | -1.13B |
| Diluted EPS | -5.95 |
| Total Cash | 2.03B |
| Total Cash/Share | 10.65 |
| Total Debt | 158.7M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 7.14 |
| Book Value Per Share | 8.58 |
| 52-Week Change | 142.48 |
| 52-Week High | 124.49 |
| 52-Week Low | 29.17 |
| Moving Average 50 Days | 101.72 |
| Moving Average 200 Days | 63.1 |
| Average Volume | 3.4M |
| Shares Outstanding | 198.17M |
| % Held by Institutions | 105.34 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |